Search - tctmd.com

Displaying 181 - 200 of 249

Sort: Relevancy | Date

News Daily News

Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6

Michael O'Riordan

September 16, 2016

News Daily News

Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities

Caitlin E. Cox

September 08, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Todd Neale

August 01, 2016

News Daily News

Heart-Healthy Lifestyle in Young Adults Impacts Daily Living Decades Later

L.A. McKeown

July 14, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Daily News

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Michael O'Riordan

June 14, 2016

News Daily News

Cardiology Groups Applaud FDA’s Draft Guidance Setting Voluntary Sodium Cuts for Processed Food Industry

Shelley Wood

June 01, 2016

News Daily News

New European Device Regulations Are Coming, Could Impact Speed of Approvals

Todd Neale

May 27, 2016

News Daily News

Treatment Duration May Explain Inconsistent Risks Seen With Testosterone Therapy

Caitlin E. Cox

May 12, 2016

News Daily News

Nestlé Voluntarily Reducing Sodium in Processed Food, but Should the AHA Applaud?

Michael O'Riordan

May 09, 2016

News Industry News

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

May 02, 2016

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as first contrast agent for use with magnetic resonance angiography of supra-aortic arteries

May 02, 2016

News Industry News

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

April 22, 2016

News Industry News

St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology

April 18, 2016

News Opinion Fellow Talk

Balancing the Bias: On Learning to Interact With Industry Reps as a Fellow

Luke Kohan, MD

March 29, 2016

News Daily News

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

Michael O'Riordan

March 09, 2016

News Daily News

A Ray of Sunshine: CMS Experts Give an Update on 2 Years of Public Disclosure

Caitlin E. Cox

March 09, 2016

News Daily News

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Michael O'Riordan

March 08, 2016

News Daily News

Cardiologist Robert Califf Becomes New Commissioner of the FDA

L.A. McKeown

February 23, 2016

Advertisement

Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6

Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities

TCTMD’s Top 10 Most Popular Stories for August 2016

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Heart-Healthy Lifestyle in Young Adults Impacts Daily Living Decades Later

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Cardiology Groups Applaud FDA’s Draft Guidance Setting Voluntary Sodium Cuts for Processed Food Industry

New European Device Regulations Are Coming, Could Impact Speed of Approvals

Treatment Duration May Explain Inconsistent Risks Seen With Testosterone Therapy

Nestlé Voluntarily Reducing Sodium in Processed Food, but Should the AHA Applaud?

Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation

FDA approves Bayer's Gadavist® (gadobutrol) injection as first contrast agent for use with magnetic resonance angiography of supra-aortic arteries

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology

Balancing the Bias: On Learning to Interact With Industry Reps as a Fellow

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

A Ray of Sunshine: CMS Experts Give an Update on 2 Years of Public Disclosure

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Cardiologist Robert Califf Becomes New Commissioner of the FDA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content